Woman who had child with brain damage and CP never had studies and testing done.
A Virginia woman, who delivered a child in 1997 with brain damage and later cerebral palsy, considered having another child in 2000. In discussing the risks of another pregnancy with a physician, she revealed she had lupus, migraine headaches, and supraventricular tachycardia that was treated with beta-blockers. She was told the risk of a brain hemorrhage like the one that caused her first child's damage could be reduced by regular monitoring for fetal growth, tracking of fetal movements, and FHR testing. When asked about the results from those tests in her first pregnancy, she informed them she had no such studies done. She said her physicians involved with the first delivery told her the child's problems were due to a placental abruption.
Once she learned this type of testing was standard of care for women with her medical conditions, she discovered further that a specialist had been consulted during her first pregnancy who did recommend testing, but these suggestions were not discussed with her nor were the tests performed.
The woman sued those involved with the first delivery and claimed that IUGR had occurred due to her lupus and the beta-blocker she took and that additional fetal monitoring was required when this was recognized. The child was born about a month early due to fetal distress and at age 9 had an IQ of 48 and functioned at the level of a child less than 3-years-old. A $28 million award was granted.
Study reports reduced SSI odds after gynecologic surgery from metronidazole and cefazolin
September 19th 2024A recent study shows that adding metronidazole to cefazolin significantly lowers the risk of surgical site infections in gynecologic cancer surgeries, enhancing patient outcomes.
Read More
Increase in ED visits for hypertensive disorders from 2006 to 2020 reported
September 18th 2024In a recent study, reported rates on emergency department utilization for hypertensive disorders of pregnancy and the postpartum period were higher in 2020 than 2006, with rates especially high among non-Hispanic Black, Hispanic, and Asian patients.
Read More